| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5658422 | Gastroenterology | 2017 | 33 Pages |
Abstract
IL28 controls proliferation of IECs in mice with colitis and accelerates mucosal healing by activating STAT1. IL28 might be developed as a therapeutic agent for patients with IBD.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Mircea T. Chiriac, Barbara Buchen, Alexandra Wandersee, Gheorghe Hundorfean, Claudia Günther, Yvonne Bourjau, Sean E. Doyle, Benjamin Frey, Arif B. Ekici, Christian Büttner, Benno Weigmann, Raja Atreya, Stefan Wirtz, Christoph Becker, Jürgen Siebler,